InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
T+90 hit rate
93%
T+90 mean return
+12.2%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by MCENANY PATRICK J, Chairman & CEO. Insider active across 1 company, notably Catalyst Pharmaceuticals, INC.. Aggregated, 24 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €1.2m. Activity tracked since 13 August 2021. The latest transaction was filed on 19 November 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations24 total
26,334 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000493:0
6,786 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000493:1
3,533 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000504:0
98,345 shares@ US$3.546.9% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000457:0
92,500 shares@ US$3.546.4% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000447:0
230,000 shares@ US$4.0118.0% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000445:0
5,100 shares0Common Stock, par value $0.001 per shareSEC:0001161697-24-000377:0
45,000 shares0Common Stock, par value $0.001 per shareSEC:0001161697-24-000362:0
26,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000055:0
250,000 shares@ US$1.135.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000025:0
26,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000649:0
26,151 shares@ US$0.790.4% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000300:0
58,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000131:0
10,000 shares0Common stock, par value $0.001 per shareSEC:0001161697-22-000615:0
30,834 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-22-000575:0
350,000 shares@ US$2.2415.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000556:0
80,765 shares@ US$15.32925.9% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000457:0
25,000 shares@ US$2.531.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000399:0
30,833 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000565
30,833 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000565:0
80,000 shares@ US$3.120.0056% mcap22.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000406:0
80,000 shares@ US$3.124.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000406
100,000 shares@ US$3.120.0070% mcap27.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000387:0
100,000 shares@ US$3.125.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000387
24 of 24 declarations
About MCENANY PATRICK J
Patrick J. McEnany is the President and CEO of Catalyst Pharmaceuticals, Inc., a biopharmaceutical company. In this role, he is responsible for the strategic direction of the company and the management of its operations. With extensive experience in the biopharmaceutical sector, he plays a key role in developing new treatments and driving innovation.
